Search Results 1-10 of 16844 for Imiglucerase
Description. Imiglucerase injection is used to treat type 1 or type 3 Gaucher disease which may cause anemia (low number of red blood cells), ...
Alglucerase is used to treat Gaucher's disease caused by the lack of a certain enzyme, glucocerebrosidase, in the body. This enzyme is necessary for your body ...
If you are also using imiglucerase, velaglucerase alfa, or taliglucerase alfa, take eliglustat 24 hours after taking the last dose of these medicines. Avoid ...
Description. Miglustat is used to treat mild to moderate type 1 Gaucher disease in people who cannot be treated with an enzyme replacement therapy.
Imiglucerase (intravenous route) · Imipenem and cilastatin (intravenous route, intramuscular route) · Imipenem, cilastatin, and relebactam (intravenous route).
These patients are at high risk for progression of kidney disease, which can result in end-stage renal failure. Participation eligibility. Participant ...
Umbralisib is used to treat marginal zone lymphoma (MZL) that has come back (relapsed) or did not respond to the treatment (refractory) in patients who have ...
Description. Alglucosidase alfa injection is an enzyme used to treat Pompe disease (glycogen storage disease type II), including infantile-onset Pompe ...
Carglumic acid is used together with diet and other medicines to treat and prevent hyperammonemia (too much ammonia in the blood) caused by the lack of a liver ...
Idarucizumab injection is used in patients who are taking dabigatran (a blood thinner) during emergency or life-threatening situations when bleeding cannot be ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!